About Us

About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

10x Genomics’s Q2 Earnings Call: Our Top 5 Analyst Questions

By: StockStory

TXG Cover Image

10x Genomics delivered second quarter results that exceeded Wall Street’s expectations, but the market responded negatively, reflecting continued concerns about the company’s end-market dynamics. Management highlighted that growth was powered by strong adoption of new single cell and spatial biology platforms, notably Chromium Flex and Xenium. CEO Serge Saxonov explained that while consumables volume increased, especially for newer products, persistent challenges in academic and government funding extended sales cycles and led to ongoing capital equipment constraints. Saxonov cited, “The academic funding landscape remains marked by shifting policies, weaker grant disbursements and lack of clarity around future budgets, all of which are contributing to extended project timelines and cautious customer spending.”

Is now the time to buy TXG? Find out in our full research report (it’s free).

10x Genomics (TXG) Q2 CY2025 Highlights:

  • Revenue: $172.9 million vs analyst estimates of $139.5 million (12.9% year-on-year growth, 24% beat)
  • Adjusted EPS: $0.48 vs analyst estimates of -$0.08 (significant beat)
  • Adjusted EBITDA: $40.77 million vs analyst estimates of -$41.5 million (23.6% margin, significant beat)
  • Revenue Guidance for Q3 CY2025 is $142 million at the midpoint, below analyst estimates of $144.2 million
  • Operating Margin: 17.4%, up from -27.3% in the same quarter last year
  • Market Capitalization: $1.69 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From 10x Genomics’s Q2 Earnings Call

  • Patrick Donnelly (Citi) asked about visibility into academic funding trends and customer confidence. CEO Serge Saxonov responded that, while optimism has slightly improved, customers remain cautious due to slow grant allocations and uncertain budgets, stating, "Budgets are still very much in the early phases, and it’s quite uncertain where they’re going to be."

  • Daniel Arias (Stifel) questioned the strategic rationale for acquiring Scale Biosciences. Saxonov explained the move was to accelerate technology integration for larger-scale, lower-cost single cell analysis, emphasizing it is a technology acquisition to enhance the existing product portfolio.

  • Madeline Mollman (Wolfe Research) inquired about the impact of lower pricing on consumables revenue and whether the Scale acquisition could intensify this trend. Saxonov acknowledged near-term pricing headwinds but reiterated that increased experiment volumes should drive long-term growth.

  • Michael Ryskin (Bank of America) sought clarification on the size and sustainability of the China order pull-forward. Saxonov and Taich emphasized their strong visibility into customer inventory and said the $4 million pull-forward was a one-time effect tied to tariff timing.

  • Thomas VonDerVellen (Guggenheim) asked about the company’s cost structure and readiness for potential further cuts. Saxonov stated that recent headcount reductions and commercial restructuring have positioned 10x Genomics well, and management remains focused on cost discipline amid an uncertain environment.

Catalysts in Upcoming Quarters

Looking ahead, our analyst team will monitor (1) the pace of adoption and expansion of new single cell and spatial products, particularly Flex v2 and Xenium enhancements, (2) signs of improvement or further deterioration in academic and government funding, and (3) the integration and strategic impact of the Scale Biosciences acquisition. Progress in broadening product applications and customer feedback on pricing elasticity will also be important indicators of future performance.

10x Genomics currently trades at $13.79, up from $12.78 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

More News

View More
3 Overlooked Value Stocks Set to Surge as Rates Drop
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers CAVA CMG LULU UPS
Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
Via MarketBeat
Topics Economy
Tickers HIMS
After the Fed's Rate Cut, PNC Could See a Mortgage Refinance Boom
Via MarketBeat
Topics Economy
Tickers PNC
AIRO Group's Pullback: An Undervalued Growth Opportunity?
Via MarketBeat
Topics Supply Chain
Tickers AIRO
Caterpillar Stock Hits All-Time High—Is There More Room to Run?
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Tickers CAT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.